The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 20, 2009

Filed:

Jun. 25, 2004
Applicants:

Theodore A. Yednock, Forest Knolls, CA (US);

Stephen B. Freedman, San Francisco, CA (US);

Ivan Lieberburg, Berkeley, CA (US);

Michael A. Pleiss, Sunnyvale, CA (US);

Andrei W. Konradi, San Francisco, CA (US);

George Shopp, South San Francisco, CA (US);

Elizabeth Messersmith, El Cerrito, CA (US);

Inventors:

Theodore A. Yednock, Forest Knolls, CA (US);

Stephen B. Freedman, San Francisco, CA (US);

Ivan Lieberburg, Berkeley, CA (US);

Michael A. Pleiss, Sunnyvale, CA (US);

Andrei W. Konradi, San Francisco, CA (US);

George Shopp, South San Francisco, CA (US);

Elizabeth Messersmith, El Cerrito, CA (US);

Assignee:

Elan Pharmaceuticals Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/24 (2006.01); A61K 31/255 (2006.01); A61K 31/195 (2006.01); C07D 239/50 (2006.01); C07C 69/75 (2006.01); C07C 229/36 (2006.01); C07C 229/40 (2006.01);
U.S. Cl.
CPC ...
Abstract

This application relates to methods and compositions for treating rheumatoid arthritis by administering a combination therapy comprising methotrexate and an antibody to alpha-4 integrin or an immunologically active antigen binding fragment in therapeutically effective amounts. The application also relates generally to methods and compositions for treating rheumatoid arthritis by administering a combination therapy comprising methotrexate and small molecule alpha-4 integrin antagonist that inhibits the alpha-4 integrin (α4 integrin) interaction with VCAM-1. The invention further relates to methods of preparing the compounds and methods of using the compounds and compositions.


Find Patent Forward Citations

Loading…